Patent classifications
C07D313/00
Olefin metathesis catalysts
The present invention refers to novel ruthenium-based catalysts for olefin metathesis reactions, particularly to fast initiating catalysts having stereoselective properties. In olefin metathesis reactions, the disclosed catalysts provide a high catalytic activity combined with the capability to generate higher yields of the olefin metathesis product.
Process Involving Cross Metathesis of Olefins
A method of forming a macrocyclic musk compound comprising the steps of: i) cross-metathesizing a first olefin and a second olefin in the presence of a homogeneous transition metal catalyst comprising an alkylidene ligand, to form a statistical mixture of a hetero-dimer intermediate of said first and second terminal olefin, and homo-dimers ii) separating the hetero-dimer from the statistical mixture of hetero- and homo-dimers iii) and cyclizing the hetero-dimer intermediate to form the macrocyclic musk compound.
Process Involving Cross Metathesis of Olefins
A method of forming a macrocyclic musk compound comprising the steps of: i) cross-metathesizing a first olefin and a second olefin in the presence of a homogeneous transition metal catalyst comprising an alkylidene ligand, to form a statistical mixture of a hetero-dimer intermediate of said first and second terminal olefin, and homo-dimers ii) separating the hetero-dimer from the statistical mixture of hetero- and homo-dimers iii) and cyclizing the hetero-dimer intermediate to form the macrocyclic musk compound.
Synthesis of resorcylic acid lactones useful as therapeutic agents
Disclosed are macrocyclic compounds of formulae I, I, II, II, III, III, IV, and V, which are analogs of the pochonin resorcylic acid lactones, pharmaceutical compositions comprising the compounds, and methods and uses comprising the compounds for the treatment of diseases mediated by kinases and Heat Shock Protein 90 HSP90.
Synthesis of resorcylic acid lactones useful as therapeutic agents
Disclosed are macrocyclic compounds of formulae I, I, II, II, III, III, IV, and V, which are analogs of the pochonin resorcylic acid lactones, pharmaceutical compositions comprising the compounds, and methods and uses comprising the compounds for the treatment of diseases mediated by kinases and Heat Shock Protein 90 HSP90.
SPINOSYN DERIVATIVES AS INSECTICIDES
Compositions and methods for the production of derivatives of spinosyns are provided. The method produces spinosyn derivatives that exhibit activity towards insects, arachnids, and/or nematodes and are useful in the agricultural and animal health markets.
USE OF PICOLINAMIDE COMPOUNDS AS FUNGICIDES
This disclosure relates to picolinamides of Formula I and their use as fungicides.
##STR00001##
USE OF PICOLINAMIDE COMPOUNDS AS FUNGICIDES
This disclosure relates to picolinamides of Formula I and their use as fungicides.
##STR00001##
PREPARATION OF MACROCYCLIC LACTONES
A process for preparing a macrocyclic lactone comprising 14 to 17 ring carbon atoms, the process comprising the steps of i) subjecting a reaction mixture comprising an olefin-containing random polyester, formed by metathesis to a cyclo-depolymerization reaction to form the macrocyclic lactone, and ii) concomitant removal of the macrocyclic lactone from the reaction mixture.
PREPARATION OF MACROCYCLIC LACTONES
A process for preparing a macrocyclic lactone comprising 14 to 17 ring carbon atoms, the process comprising the steps of i) subjecting a reaction mixture comprising an olefin-containing random polyester, formed by metathesis to a cyclo-depolymerization reaction to form the macrocyclic lactone, and ii) concomitant removal of the macrocyclic lactone from the reaction mixture.